Alfacalcidol

Jump to navigation Jump to search
Template:Chembox E number
Alfacalcidol
Names
IUPAC name
(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-7a-Methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
Other names
Alphacalcidol; 1-Hydroxycholecalciferol
Identifiers
3D model (JSmol)
ChEBI
ChEMBL
ChemSpider
DrugBank
ECHA InfoCard Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value).
KEGG
UNII
Properties
C27H44O2
Molar mass 400.64 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is ☑Y☒N ?)
Infobox references

WikiDoc Resources for Alfacalcidol

Articles

Most recent articles on Alfacalcidol

Most cited articles on Alfacalcidol

Review articles on Alfacalcidol

Articles on Alfacalcidol in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Alfacalcidol

Images of Alfacalcidol

Photos of Alfacalcidol

Podcasts & MP3s on Alfacalcidol

Videos on Alfacalcidol

Evidence Based Medicine

Cochrane Collaboration on Alfacalcidol

Bandolier on Alfacalcidol

TRIP on Alfacalcidol

Clinical Trials

Ongoing Trials on Alfacalcidol at Clinical Trials.gov

Trial results on Alfacalcidol

Clinical Trials on Alfacalcidol at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Alfacalcidol

NICE Guidance on Alfacalcidol

NHS PRODIGY Guidance

FDA on Alfacalcidol

CDC on Alfacalcidol

Books

Books on Alfacalcidol

News

Alfacalcidol in the news

Be alerted to news on Alfacalcidol

News trends on Alfacalcidol

Commentary

Blogs on Alfacalcidol

Definitions

Definitions of Alfacalcidol

Patient Resources / Community

Patient resources on Alfacalcidol

Discussion groups on Alfacalcidol

Patient Handouts on Alfacalcidol

Directions to Hospitals Treating Alfacalcidol

Risk calculators and risk factors for Alfacalcidol

Healthcare Provider Resources

Symptoms of Alfacalcidol

Causes & Risk Factors for Alfacalcidol

Diagnostic studies for Alfacalcidol

Treatment of Alfacalcidol

Continuing Medical Education (CME)

CME Programs on Alfacalcidol

International

Alfacalcidol en Espanol

Alfacalcidol en Francais

Business

Alfacalcidol in the Marketplace

Patents on Alfacalcidol

Experimental / Informatics

List of terms related to Alfacalcidol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [4]

Overview

Alfacalcidol (or 1-hydroxycholecalciferol) is an analogue of vitamin D used for supplementation in humans and as a poultry feed additive.

Alfacalcidol has a weaker impact on calcium metabolism[1] and parathyroid hormone levels[2] than calcitriol, however alfacalcidiol has significant effects on the immune system, including regulatory T cells.[3] It is considered to be a more useful form of vitamin D supplementation, mostly due to much longer half-life and lower kidney load.[4] It is the most commonly prescribed vitamin D metabolite for patients with end stage renal disease, given that impaired renal function alters the ability to carry out the second hydroxylation step required for the formation of the physiologically active form of vitamin D, 1,25-dihydroxyvitamin D3. Alfacalcidol is an active vitamin D3 metabolite, and therefore does not require the second hydroxylation step in the kidney. [5]


Used as a poultry feed additive, it prevents tibial dyschondroplasia and increases phytate bioavailability.[6]OR

References

  1. Biological effects of various regimes of 25-hydroxyvitamin D3 (calcidiol) administration on bone mineral metabolism in postmenopausal women, Clin Cases Miner Bone Metab. 2009 May–Aug; 6(2): 169–173; [1]
  2. Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: a randomized, crossover trial, Can J ,Clin Pharmacol Vol 15 (1) Winter 2008:e36 -e43; January 9, 2008; [2]
  3. Alfacalcidol treatment restores derailed immune-regulation in patients with undifferentiated connective tissue disease, Autoimmunity Reviews, August 2010;
  4. Superiority of alfacalcidol compared to vitamin D plus calcium in lumbar bone mineral density in postmenopausal osteoporosis, Rheumatol Int. 2006 Mar;26(5):445-53. Epub 2005 Nov 10; [3]
  5. Alfacalcidol in the therapy of renal bone disease. Ritzerfeld M, Klasser M, Mann H. Int J Clin Pharmacol Ther. 2001 Dec;39(12):546-50.PMID:11770836
  6. VDI Product Data